Company records / confotherapeutics.com

Confo Therapeutics

Confo Therapeutics (confotherapeutics.com): 1 change recorded in its website history since July 2025. Homepage last checked 5 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

FundingBetween 22 July 2025 and 30 April 2026
Announced on its homepage: “Confo Therapeutics Announces EUR 60M Series B Financing to Advance a Pipeline of Novel GPCR-Modulating Therapies into Clinical Developmen…”.
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation

First recorded website

Observed 22 July 2025

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Pioneering novel GPCR-directed therapeutics for metabolic & endocrine diseases

Confo Therapeutics is a clinical-stage company committed to accelerating novel GPCR-directed medicines for metabolic & endocrine diseases.

Homepage

Funding statements on the website: Confo Therapeutics Announces EUR 60M Series B Financing to Advance a Pipeline of Novel GPCR-Modulating Therapies into Clinical Development Press release

archived page Link to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

July 2025 – November 2026 · 4 captures · latest observed messagingPioneering novel GPCR-directed therapeutics for metabolic & endocrine diseases
Confo Therapeutics is a clinical-stage company committed to accelerating novel GPCR-directed medicines for metabolic & endocrine diseases.
This wording observed 5 November 2026.
current websiteHistorical capture not publicly available
Inspect 4 captures in this group
- 22 July 2025 · Pioneering novel GPCR-directed therapeutics for metabolic & endocrine diseases archived page
- 30 April 2026 · Pioneering novel GPCR-directed therapeutics for metabolic & endocrine diseases archived page
- 11 July 2026 · Pioneering novel GPCR-directed therapeutics for metabolic & endocrine diseases archived page
- 5 November 2026 · Pioneering novel GPCR-directed therapeutics for metabolic & endocrine diseases current websiteHistorical capture not publicly available

Cite this record

StartupHistory, “Confo Therapeutics” company record, https://startuphistory.org/c/confotherapeutics.com

Machine-readable: /c/confotherapeutics.com.json. How changes are found: method.